1. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Issue 10 (October 2016) Authors: Kaufman, Howard L; Russell, Jeffery; Hamid, Omid; Bhatia, Shailender; Terheyden, Patrick; D'Angelo, Sandra P; Shih, Kent C; Lebbé, Céleste; Linette, Gerald P; Milella, Michele; Brownell, Isaac; Lewis, Karl D; Lorch, Jochen H; Chin, Kevin; Mahnke, Lisa; von Heydebreck, Anja; Cuillerot, Jean-Marie;... Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial. Issue 1 (15th May 2020) Authors: D'Angelo, Sandra P; Bhatia, Shailender; Brohl, Andrew S; Hamid, Omid; Mehnert, Janice M; Terheyden, Patrick; Shih, Kent C; Brownell, Isaac; Lebbé, Celeste; Lewis, Karl D; Linette, Gerald P; Milella, Michele; Georges, Sara; Shah, Parantu; Ellers-Lenz, Barbara; Bajars, Marcis; Güzel, Gülseren; Nghi... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗